SCHEMBL16367709

SCHEMBL16367709

COCCOCc1nc(-c2ccc(C)c(C)c2)no1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 13/20 0.57
▸ TSHR P16473 5/20 0.57
▸ MAPK1 P28482 5/20 0.49
▸ POLB P06746 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ S1PR1 P21453 2/20 0.46
▸ NPY1R P25929 1/20 0.46
▸ NPY2R P49146 1/20 0.46
▸ S1PR3 Q99500 1/20 0.46
▸ TDP1 Q9NUW8 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ TP53 P04637 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14741741 0.89 MAPT (0.48) MAPTTSHRMAPK1POLBTHRB
SCHEMBL14679171 0.85 TDP1 (0.56) MAPTTSHRMAPK1TDP1L3MBTL1
SCHEMBL14741829 0.84 KIT (0.49) MAPTTSHRMAPK1THRBTP53
SCHEMBL14757481 0.80 MAPK1 (0.46) MAPTTSHRMAPK1THRBS1PR1
SCHEMBL3117170 0.78 TDP1 (0.43) MAPTTSHRMAPK1POLBNPY1R
SCHEMBL16375260 0.78 MAPT (0.47) MAPTTSHRMAPK1THRBTP53
SCHEMBL16202099 0.77 S1PR1 (0.55) MAPTTSHRMAPK1POLBS1PR1
SCHEMBL3749587 0.77 MAP4K4 (0.50) MAPTTSHRMAPK1S1PR1S1PR3
SCHEMBL28869598 0.76 MAPT (0.52) MAPTTSHRMAPK1POLBTHRB
SCHEMBL7803358 0.76 MAPT (0.64) MAPTTSHRMAPK1POLBTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150011508-A1 COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS IRM LLC (BM) 2015-01-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150011508-A1 COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS KIT, PDGFRA, PDGFRB MAPT 3899/4885TSHR 4651/4885MAPK1 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback